UConn Health
health.uconn.eduTotal trials
185
Active
27
Phase 3
9
Total enrollment
42,346
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Gadopiclenol | — | — | — | — | — | 1 | |
| Gadobutrol | — | — | — | — | — | 1 | |
| Levothyroxine | — | — | — | — | — | 1 | |
| Levothyroxine/Liothyronine once daily | — | — | — | — | — | 1 | |
| Levothyroxine/Liothyronine twice daily | — | — | — | — | — | 1 | |
| Mitoquinone Mesylate | — | — | — | — | — | 1 | |
| Amino acid supplement | — | — | — | — | — | 1 |
Next readouts
- 2025-09
- 2026-06-30
- 2027-03-01
- 2027-12-31
Top conditions
- Substance Abuse11
- Alcoholism10
- Alcohol Abuse9
- Contingency Management8
- Alcohol Dependence6
- Gambling5
- Nicotine Dependence5
- Cigarette Smoking5
Frequently asked questions about UConn Health
- How many clinical trials does UConn Health have on ClinicalTrials.gov?
- UConn Health is listed as the lead sponsor on 185 clinical trials in ClinicalTrials.gov, 27 of which are currently active (recruiting, enrolling, or ongoing).
- How many of UConn Health's trials are in Phase 3?
- 9 of UConn Health's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does UConn Health focus on?
- UConn Health's most-studied conditions on ClinicalTrials.gov are Substance Abuse, Alcoholism, Alcohol Abuse, Contingency Management, Alcohol Dependence.
- When are UConn Health's next clinical trial readouts?
- UConn Health has 4 upcoming primary-completion readouts tracked here; the soonest is “A Targeted Amino Acid Supplement for People With Parkinson's Disease”, expected around 2025-09.